Skip to content

Screener

Eligibility screening

MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies

Sponsored by MacroGenicsStudy detailsClinicalTrials.gov

7 US sites in CO, MA, MD, MI +3

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.